Butorphanol tartrate

Butorphanol tartrate
Product Description

Butorphanol tartrate is a synthetic opioid analgesic and is used for the management of moderate to severe pain, as well as for sedation in certain medical procedures.

It is commonly used in both human and veterinary medicine. In veterinary medicine, it’s often used for pre-anesthetic medication or for pain relief in dogs and cats. In human medicine, it’s sometimes administered via intranasal spray or injectable forms. The tartrate salt form improves its solubility and stability, making it suitable for injectable or other formulations.
Product status: Under development, ASMF filed end of 2025
In product pipeline. Enquire for more details.

Read more Show less

TBD Pharmatech

  • Country/Region:
    Estonia
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
CMO/CDMO
Primary activities
Analytical Services
Animal Health
API Producer
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Generic APIs producer
Intermediates Manufacturer
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    58786-99-5
  • Details
    EU GMP compliant Product type: API
    Drug class: Opioid Analgesic
    Common indications: Pain management 
More specifications Fewer specifications

TBD Pharmatech

  • Country/Region:
    Estonia
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
CMO/CDMO
Primary activities
Analytical Services
Animal Health
API Producer
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Generic APIs producer
Intermediates Manufacturer
View company profile

More Products from TBD Pharmatech (2)

  • Bortezomib

    Product Bortezomib

    Bortezomib is a targeted anticancer drug classified as a proteasome inhibitor, primarily used in the treatment of multiple myeloma and mantle cell lymphoma. It works by inhibiting the 26S proteasome, a protein complex responsible for degrading unneeded or damaged proteins within cells. By blocking this sys...
  • Pomalidomide

    Product Pomalidomide

    Pomalidomide is an oral immunomodulatory drug (IMiD) primarily used in the treatment of relapsed or refractory multiple myeloma, particularly in patients who have already received other therapies such as lenalidomide and bortezomib. Structurally related to thalidomide, pomalidomide works by modulating the ...

TBD Pharmatech resources (1)